Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000916875 | SCV001062129 | likely benign | not provided | 2023-12-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000916875 | SCV001791838 | likely benign | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002540912 | SCV003541139 | uncertain significance | Inborn genetic diseases | 2021-09-27 | criteria provided, single submitter | clinical testing | The c.368G>C (p.G123A) alteration is located in exon 4 (coding exon 3) of the DSPP gene. This alteration results from a G to C substitution at nucleotide position 368, causing the glycine (G) at amino acid position 123 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000916875 | SCV003829149 | uncertain significance | not provided | 2019-05-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000916875 | SCV004152890 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | DSPP: BP4, BS1, BS2 |